This may be possible by applying a mechanistic approach to identifying potential biomarkers such as HIF1 that could crucially determine and regulate mutual aberrations in both diabetes and breast cancer and how pre-morbiditic diabetic state may progress into a mammary cancerous state. Here, HIF1A is linked to diabetes mellitus.